Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2026-02-21 @ 6:24 AM
Study NCT ID:
NCT04812535
Status:
TERMINATED
Last Update Posted:
2025-02-11
First Post:
2021-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.
Sponsor:
InflaRx GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-04
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-10
First Submit QC Date:
None
Study First Post Date:
2021-03-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-20
Results First Submit QC Date:
None
Results First Post Date:
2025-02-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-20
Last Update Post Date:
2025-02-11
Last Update Post Date Type:
ACTUAL